Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
1) F.D.A. Toughens Warning Labels for Some Opioid Painkillers. The New York Times, March 22, 2016.
The FDA is requiring new warning labels regarding the risks of abuse and death in using opioid painkillers.
2) Task Force Finds State ‘Fundamentally Accountable’ For Flint Water Crisis. ABC News, March 23, 2016.
The state panel, appointed by Gov. Rick Snyder, found the state accountable for Flint’s lead crisis.
3) Company that Makes Sleep Apnea Masks to Pay $34M in Lawsuit. AP, March 23, 2016.
Philips Respironics Inc. has agreed to pay $34.8 million to settle claims that it paid kickbacks to suppliers.
4) U.S. FDA approves Teva’s treatment for asthma. Reuters, March 23, 2016.
Teva Pharmaceutical Industries Ltd.’s drug to treat severe asthma has been approved by the FDA.
5) FDA Approved 3D Printed Drug Available in the US. Forbes, March 22, 2016.
The first 3D printed prescription drug was approved by the FDA to treat partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. CLICK HERE TO SUBSCRIBE.
P.S. If you or your patients are interested in consumer healthcare issues, check out myhealthspin.com.
